Literature DB >> 25999298

Swiss physicians' attitudes to assisted suicide: A qualitative and quantitative empirical study.

Susanne Brauer1, Christian Bolliger2, Jean-Daniel Strub1.   

Abstract

PRINCIPLES: In Switzerland, assisted suicide is legal as long as it does not involve self-serving motives. Physician-assisted suicide is regulated by specific guidelines issued by the Swiss Academy of Medical Sciences (SAMS). This article summarises the results of an empirical study of physicians' attitudes to assisted suicide in Switzerland, which was commissioned by the SAMS. The study (in German) is available online at: www.samw.ch.
METHODS: Twelve qualitative interviews and a written survey were conducted, involving a disproportional, stratified random sample of Swiss physicians (4,837 contacted, 1,318 respondents, response rate 27%).
RESULTS: Due to the response rate and the wide variation of respondents from one professional speciality to another, the findings and interpretations presented should be regarded as applying only to the group of physicians who are interested in or are particularly affected by the issue of assisted suicide. They cannot be generalised to the whole body of physicians in Switzerland. Of the respondents, 77% considered physician-assisted suicide to be justifiable in principle, while 22% were fundamentally opposed to it. Although 43% could imagine situations where they would personally be prepared to perform assisted suicide, it is clear from the study that this potential readiness does not mean that all respondents would automatically be prepared to perform it in practice as soon as the legal criteria are met. The vast majority of respondents emphasised that there should be no obligation to perform physician-assisted suicide. Opinions differed as to whether physician-assisted suicide should remain restricted to cases where the person concerned is approaching the end of life. While a large majority of respondents considered physician-assisted suicide also to be justifiable in principle in non-end-of-life situations, 74% supported the maintenance of the end-of-life criterion in the SAMS Guidelines as a necessary condition for physician-assisted suicide. Over 50% of the respondents had never been confronted with a request for assisted suicide by a patient.
CONCLUSIONS: The vast majority of physicians surveyed considered assisted suicide to be justifiable in principle; however, their support was strongly dependent on the specific situation. The study indicates that even physicians expressing a potential readiness to perform assisted suicide themselves would not do so automatically if all the criteria for assisted suicide were met. Assisted suicide thus appears to be an exceptional situation, which physicians would only become involved in on a voluntary basis. The authors recommend that the current SAMS Guidelines regulating physician-assisted suicide in Switzerland should be reviewed with regard to the end-of-life criterion as a necessary condition for physician-assisted suicide.

Entities:  

Mesh:

Year:  2015        PMID: 25999298     DOI: 10.4414/smw.2015.14142

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  3 in total

1.  Assisted Suicide in Switzerland: An Analysis of Death Records From Swiss Institutes of Forensic Medicine.

Authors:  Christine Bartsch; Karin Landolt; Anita Ristic; Thomas Reisch; Vladeta Ajdacic-Gross
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

2.  General Practitioners' Attitudes towards Essential Competencies in End-of-Life Care: A Cross-Sectional Survey.

Authors:  Stéphanie Giezendanner; Corinna Jung; Hans-Ruedi Banderet; Ina Carola Otte; Heike Gudat; Dagmar M Haller; Bernice S Elger; Elisabeth Zemp; Klaus Bally
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

3.  Knowledge Gaps in End-of-Life Care and Planning Options Among Older Adults in Switzerland.

Authors:  Sarah Vilpert; Gian Domenico Borasio; Jürgen Maurer
Journal:  Int J Public Health       Date:  2022-08-25       Impact factor: 5.100

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.